共 158 条
[1]
Chugh SS(2014)Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study Circulation 129 837-847
[2]
Havmoeller R(2007)Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 857-3035
[3]
Narayanan K(2009)Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 1139-817
[4]
Hart RG(2011)Apixaban versus Warfarin in patients with Atrial fibrillation N Engl J Med 365 981-504
[5]
Pearce LA(2011)Rivaroxaban versus Warfarin in Nonvalvular Atrial fibrillation N Engl J Med 365 883-e332
[6]
Aguilar MI(2014)Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials Lancet 383 955-1299
[7]
Connolly SJ(2009)Medication adherence: its importance in cardiovascular outcomes Circulation 119 3028-229
[8]
Ezekowitz MD(2014)Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration Am Heart J 167 810-195
[9]
Yusuf S(2015)Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nation wide cohort study J Thromb Haemost 13 495-253
[10]
Eikelboom J(2013)Adherence, persistence, and switching patterns of dabigatran etexilate Am J Manag Care 19 e325-497